Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering

Amgen ("Amgen") (NASDAQ:

) announced today that all conditions to the closing of the tender offer by a  wholly owned subsidiary, "Merger Sub", to acquire all outstanding shares of common stock of Micromet, Inc. (NASDAQ:

) for $11.00 per share in cash have been satisfied.